4DMedical Ltd.ASX: 4DX

4DMedical receives TGA approval for CTVQ in Australia

· Issued by 4DMedical Ltd.

Filed with ASX · · 4 pages · English

Summary by 6ix AI

4DMedical Ltd. has received approval from the Therapeutic Goods Administration for its CT:VQ™ imaging solution in Australia, allowing for commercial deployment across the country. This approval marks a significant milestone as CT:VQ™ is now cleared for use in multiple international markets, enhancing its potential as a standard for functional lung assessment. The company plans to pursue Medicare reimbursement for CT:VQ™, leveraging its regulatory achievements and clinical evidence to support this initiative.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

4DMedical Ltd. on 6ix

Story so far

Earlier from 4DMedical

Later from 4DMedical

All 4DMedical news releases